Rakuten Investment Management Inc. Acquires 7,333 Shares of Astera Labs, Inc. $ALAB

Rakuten Investment Management Inc. lifted its holdings in Astera Labs, Inc. (NASDAQ:ALAB) by 17.0% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 50,571 shares of the company’s stock after buying an additional 7,333 shares during the quarter. Rakuten Investment Management Inc.’s holdings in Astera Labs were worth $18,096,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of ALAB. BlackRock Inc. purchased a new stake in Astera Labs in the second quarter worth $6,609,581,000. Atreides Management LP boosted its stake in shares of Astera Labs by 108.9% during the first quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock valued at $368,890,000 after purchasing an additional 1,754,593 shares during the period. Van ECK Associates Corp boosted its stake in shares of Astera Labs by 20.0% during the second quarter. Van ECK Associates Corp now owns 2,237,961 shares of the company’s stock valued at $1,080,980,000 after purchasing an additional 373,545 shares during the period. Bank of America Corp DE purchased a new stake in shares of Astera Labs during the second quarter valued at $1,061,791,000. Finally, Amundi grew its holdings in shares of Astera Labs by 77.9% in the first quarter. Amundi now owns 1,880,830 shares of the company’s stock worth $206,139,000 after purchasing an additional 823,477 shares during the last quarter. 60.47% of the stock is owned by institutional investors.

Astera Labs Stock Performance

NASDAQ ALAB opened at $223.27 on Thursday. The firm’s 50 day moving average price is $304.94 and its 200-day moving average price is $255.78. Astera Labs, Inc. has a 52-week low of $97.89 and a 52-week high of $499.48. The company has a market cap of $38.73 billion, a PE ratio of 88.95 and a beta of 3.85.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings data on Tuesday, November 3rd. The company reported $1.32 earnings per share for the quarter, beating analysts’ consensus estimates of $1.19 by $0.13. Astera Labs had a return on equity of 27.30% and a net margin of 29.64%. The company had revenue of $584.90 million for the quarter, compared to the consensus estimate of $550.78 million. During the same quarter last year, the company earned $0.49 earnings per share. The firm’s revenue for the quarter was up 153.6% compared to the same quarter last year. On average, analysts forecast that Astera Labs, Inc. will post 2.71 earnings per share for the current fiscal year.

Astera Labs News Summary

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Q3 earnings of $1.32 per share beat the $1.19 consensus, while revenue of $584.9 million exceeded estimates and rose 153.6% year over year. Scorpio switches, including the X-Series, were a key growth driver. Article: Astera Labs Q3 Earnings and Revenues Beat Estimates
• Positive Sentiment: Management forecast Q4 revenue of $730 million to $750 million, citing AI connectivity demand. Expansion into optical connectivity, memory and rack-scale AI systems may provide additional growth opportunities. Article: ALAB Q3 Earnings Call Highlights Scorpio Ramp and New Growth Engines
• Neutral Sentiment: Analyst opinions were mixed: Northland upgraded ALAB to Outperform and Morgan Stanley raised its price target, while several firms lowered targets; RBC maintained an Outperform rating. Article: Northland Securities stock recommendations
• Negative Sentiment: Shares fell despite the earnings beat, suggesting results and guidance may not have been enough to satisfy expectations. Analysts flagged a premium valuation, rising costs, reliance on a limited number of customers and competition—particularly Marvell’s optical push—as risks to future growth. Article: Astera Labs Stock Falls Despite Strong Earnings. Its Growth Story Is Intact.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on ALAB. UBS Group dropped their target price on shares of Astera Labs from $300.00 to $290.00 and set a “neutral” rating on the stock in a research note on Wednesday. Roth Capital reaffirmed a “buy” rating and set a $450.00 price target on shares of Astera Labs in a research note on Wednesday, August 5th. Morgan Stanley boosted their price target on Astera Labs from $382.00 to $389.00 and gave the company an “overweight” rating in a report on Wednesday. Needham & Company LLC dropped their price objective on Astera Labs from $425.00 to $300.00 and set a “buy” rating on the stock in a research note on Wednesday. Finally, Zacks Research downgraded Astera Labs from a “strong-buy” rating to a “hold” rating in a report on Monday, October 5th. Twelve investment analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the stock. According to data from MarketBeat.com, Astera Labs presently has an average rating of “Moderate Buy” and an average target price of $318.00.

Insider Buying and Selling at Astera Labs

In other news, COO Sanjay Gajendra sold 90,630 shares of the business’s stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the sale, the chief operating officer owned 1,119,038 shares in the company, valued at approximately $380,864,583.30. The trade was a 7.49% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Stefan A. Dyckerhoff sold 8,994 shares of the company’s stock in a transaction that occurred on Wednesday, October 7th. The shares were sold at an average price of $376.06, for a total transaction of $3,382,283.64. Following the transaction, the director owned 2,648 shares in the company, valued at $995,806.88. The trade was a 77.25% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders sold 396,059 shares of company stock valued at $123,408,470. Corporate insiders own 10.40% of the company’s stock.

Astera Labs Company Profile

Astera Labs, Inc is a semiconductor and connectivity solutions company that develops hardware and software for data centers, cloud computing, and artificial intelligence infrastructure. Its products are designed to help move data between processors, memory, storage, and networking components while addressing bandwidth, latency, and system-management requirements.

The company’s portfolio includes Aries PCI Express and Compute Express Link (CXL) Smart Retimers, Taurus Ethernet Smart Cable Modules, Scorpio Smart Fabric Switches, and Leo CXL Memory Connectivity Controllers.